The role of Asprosin in patients with dilated cardiomyopathy
The role of Asprosin in patients with dilated cardiomyopathy
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Asprosin is a novel fasting glucogenic adipokine discovered in 2016. Asprosin induces rapid glucose releases from the liver. However, its molecular mechanisms and function are still unclear. Adaptation of energy substrates from fatty acid to glucose is recently considered a novel therapeutic target in heart failure treatment. We hypothesized that t...
Alternative Titles
Full title
The role of Asprosin in patients with dilated cardiomyopathy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5031a35ec213467b8dc4fdcca6428291
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5031a35ec213467b8dc4fdcca6428291
Other Identifiers
ISSN
1471-2261
E-ISSN
1471-2261
DOI
10.1186/s12872-020-01680-1
